GILEAD SCIENCES, INC.
GILD
51 insider filings · Latest: Aug 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jan 23, 2026 | Jan 23 9:03 PM | DANIEL O'DAY | Proposed Sale | 115,640 | $135.00 | $15.6M | — | View → |
| Jan 22, 2026 | Jan 22 9:32 PM | DEBORAH TELMAN | Proposed Sale | 29,215 | $129.11 | $3.8M | — | View → |
| Jan 20, 2026 | Jan 21 9:26 PM | Jeffrey BluestoneDirector | Sale | 5,000 | $123.50 | $617.5K | 8,920(D) | View → |
| Jan 20, 2026 | Jan 20 9:01 PM | JEFFREY BLUESTONE | Proposed Sale | 5,000 | $123.50 | $617.5K | — | View → |
| Jan 15, 2026 | Jan 16 11:18 PM | Andrew D DickinsonChief Financial Officer | Sale | 3,000 | $124.31 | $372.9K | 150,503(D) | View → |
| Jan 15, 2026 | Jan 16 11:10 PM | Johanna MercierChief Commercial Officer | Sale | 3,000 | $124.31 | $372.9K | 103,221(D) | View → |
| Jan 15, 2026 | Jan 15 9:02 PM | JOHANNA MERCIER | Proposed Sale | 3,000 | $124.31 | $372.9K | — | View → |
| Jan 15, 2026 | Jan 15 9:01 PM | ANDREW DICKINSON | Proposed Sale | 3,000 | $124.31 | $372.9K | — | View → |
| Dec 29, 2025 | Dec 29 9:04 PM | DANIEL O'DAY | Proposed Sale | 10,000 | $124.83 | $1.2M | — | View → |
| Dec 15, 2025 | Dec 15 9:04 PM | JOHANNA MERCIER | Proposed Sale | 3,000 | $122.00 | $366.0K | — | View → |
| Dec 15, 2025 | Dec 15 9:04 PM | ANDREW DICKINSON | Proposed Sale | 3,000 | $122.00 | $366.0K | — | View → |
| Nov 28, 2025 | Nov 28 6:05 PM | DANIEL O'DAY | Proposed Sale | 10,000 | $126.54 | $1.3M | — | View → |
| Nov 28, 2025 | Nov 28 6:02 PM | JEFFREY BLUESTONE | Proposed Sale | 5,000 | $125.08 | $625.4K | — | View → |
| Nov 26, 2025 | Nov 26 9:16 PM | KELLY KRAMER | Proposed Sale | 5,611 | $127.12 | $713.3K | — | View → |
| Nov 17, 2025 | Nov 17 9:06 PM | JOHANNA MERCIER | Proposed Sale | 28,000 | $125.86 | $3.5M | — | View → |
| Nov 17, 2025 | Nov 17 9:05 PM | ANDREW DICKINSON | Proposed Sale | 2,500 | $125.23 | $313.1K | — | View → |
| Nov 13, 2025 | Nov 13 10:07 PM | DIANE E WILFONG | Proposed Sale | 3,500 | $127.02 | $444.6K | — | View → |
| Nov 12, 2025 | Nov 12 9:36 PM | DEBORAH TELMAN | Proposed Sale | 55,646 | $122.56 | $6.8M | — | View → |
| Oct 28, 2025 | Oct 28 9:47 PM | DANIEL ODAY | Proposed Sale | 10,000 | $119.39 | $1.2M | — | View → |
| Oct 15, 2025 | Oct 15 8:05 PM | ANDREW DICKINSON | Proposed Sale | 2,500 | $118.08 | $295.2K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 10, 2026 | Mar 12 8:39 PM | Wettan Keeley M CainEVP Gen Counsel, Legal & Comp | Grant/Award | 23,935 | $148.56 | 18,885(D) | View → |
| Mar 10, 2026 | Mar 12 8:37 PM | Erin BurkhartSVP, Controllership | Grant/Award | 7,810 | $148.56 | 5,455(D) | View → |
| Mar 10, 2026 | Mar 12 8:24 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Grant/Award | 155,570 | $148.56 | 122,755(D) | View → |
| Mar 10, 2026 | Mar 12 8:24 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Option Exercise | 20,026 | — | 68,044(D) | View → |
| Mar 10, 2026 | Mar 12 8:22 PM | Dietmar BergerChief Medical Officer | Grant/Award | 39,890 | $148.56 | 31,475(D) | View → |
| Mar 10, 2026 | Mar 12 8:22 PM | Dietmar BergerChief Medical Officer | Option Exercise | 2,133 | — | 39,046(D) | View → |
| Feb 17, 2026 | Feb 18 10:22 PM | Johanna MercierChief Comm & Corp Aff Officer | Option Exercise | 25,000 | $66.64 | 48,110(D) | View → |
| Feb 5, 2026 | Feb 6 9:22 PM | Daniel Patrick O'DayDirector, Chairman & CEO | Option Exercise | 115,640 | $66.01 | 0(D) | View → |
| Jan 23, 2026 | Jan 27 12:29 AM | Daniel Patrick O'DayDirector, Chairman & CEO | Option Exercise | 115,640 | $66.01 | 115,640(D) | View → |
| Jan 20, 2026 | Jan 21 9:26 PM | Jeffrey BluestoneDirector | Option Exercise | 5,000 | $67.45 | 4,665(D) | View → |
← Previous
Page 2 of 2